Holen Sie sich die Stockscreener-App
218.58
3.38%
7.15
Vorhandelsmarkt:
220.07
1.49
+0.68%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$211.43
Offen:
$211.5
24-Stunden-Volumen:
773.24K
Relative Volume:
0.92
Marktkapitalisierung:
$15.70B
Einnahmen:
$2.90B
Nettoeinkommen (Verlust:
$467.20M
KGV:
34.31
EPS:
6.37
Netto-Cashflow:
$306.90M
1W Leistung:
+3.86%
1M Leistung:
+3.60%
6M Leistung:
-31.31%
1J Leistung:
-31.20%
1-Tages-Spanne:
$209.32
$221.00
1-Wochen-Bereich:
$206.10
$221.00
52-Wochen-Spanne:
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
218.58 | 15.12B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
558.06 | 199.19B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
171.03 | 49.82B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.93 | 42.71B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
249.69 | 35.94B | 5.02B | 1.31B | 1.56B | 8.91 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit - TradingView
WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc.July 7, 2025 Deadline - ACCESS Newswire
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit - Longview News-Journal
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical Services, Inc. (WST), Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST - GlobeNewswire Inc.
Transcript : West Pharmaceutical Services, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-05-2025 10 - marketscreener.com
West Pharmaceutical at William Blair Conference: Strategic Growth Insights - Investing.com
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. - GlobeNewswire
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 – WST - TradingView
Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) InvestorsLead Plaintiff Deadline on July 7, 2025 - ACCESS Newswire
Contact The Gross Law Firm by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc.(WST) - PR Newswire
Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
West Pharmaceutical Services, Inc. Sued for Securities Law - GlobeNewswire
West Pharmaceutical Services, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – WST - TradingView
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
West Pharmaceutical Services: Mixed Results And A Pricey Stock Makes This A Pass (WST) - Seeking Alpha
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025 - ACCESS Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - TradingView
Deadline Alert: West Pharmaceutical Services, Inc. (WST) - GlobeNewswire
If you are a Long-Term Shareholder of DoubleVerify - GlobeNewswire
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your RightsContact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025Contact Levi & Korsinsky - ACCESS Newswire
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) -Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued? - Yahoo Finance
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. InvestorsLead Plaintiff Deadline July 7, 2025 - ACCESS Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to ... - Enidnews.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages West - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider
Class Action Filed Against West Pharmaceutical Services, - GlobeNewswire
Class Action Filed Against West Pharmaceutical Services, Inc. (WST)July 7, 2025 Deadline to ... - Bluefield Daily Telegraph
Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025 - ACCESS Newswire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Treace Medical Concepts, Inc. (NASDAQ: TMCI); Virtu Financial Inc. (NASDAQ: VIRT); and West Pharmaceutical Services, Inc. (NYSE: WS - Morningstar
WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - marketscreener.com
Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire
3 Dividend Aristocrats Wall Street Says Can Soar 48% in 2025 - 24/7 Wall St.
Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact Levi & Korsinsky about pending Class ActionWST - PR Newswire
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - Insider Monkey
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST - TradingView
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
The Gross Law Firm Notifies Shareholders of West - GlobeNewswire
The Gross Law Firm Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class ... - Bluefield Daily Telegraph
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):